FTC Approves Final Order Preserving Competition in Markets for 79 Pharmaceutical Products
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Teva Pharmaceutical Industries Ltd.’s $40.5 billion acquisition of Allergan plc’s...